Anti-cgrp Monoclonal Antibodies in Chronic Migraine Prophilaxys: Efficacy and Safety in Patients Treated With Botulinum Toxin aCalogera Butera, Ubaldo Del Carro, Roberto Santangelo et al.|Research Square|2023Cited by 1
Efficacy and safety of anti-CGRP monoclonal antibodies for chronic migraine prophylaxis in patients treated with botulinum toxin A: A prospective monocentric studyCalogera Butera, Ubaldo Del Carro, Ilaria Cetta et al.|Cephalalgia Reports|2024Cited by 0